FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.
Oncologist
; 22(11): 1347-1353, 2017 11.
Article
in En
| MEDLINE
| ID: mdl-28904172
Full text:
1
Collection:
01-internacional
Health context:
3_ND
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Drug Resistance, Neoplasm
/
Antibodies, Monoclonal
/
Multiple Myeloma
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Oncologist
Year:
2017
Document type:
Article